BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37390759)

  • 1. Spatially-aware clustering improves AJCC-8 risk stratification performance in oropharyngeal carcinomas.
    Canahuate G; Wentzel A; Mohamed ASR; van Dijk LV; Vock DM; Elgohari B; Elhalawani H; Fuller CD; Marai GE
    Oral Oncol; 2023 Sep; 144():106460. PubMed ID: 37390759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging HPV-related oropharyngeal cancer: Validation of AJCC-8 in a surgical cohort.
    Geltzeiler M; Bertolet M; Albergotti W; Gleysteen J; Olson B; Persky M; Gross N; Li R; Andersen P; Kim S; Ferris RL; Duvvuri U; Clayburgh D
    Oral Oncol; 2018 Sep; 84():82-87. PubMed ID: 30115481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
    Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oropharyngeal cancer patient stratification using random forest based-learning over high-dimensional radiomic features.
    Patel H; Vock DM; Marai GE; Fuller CD; Mohamed ASR; Canahuate G
    Sci Rep; 2021 Jul; 11(1):14057. PubMed ID: 34234160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
    Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
    Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
    Ho AS; Luu M; Kim S; Tighiouart M; Mita AC; Scher KS; Mallen-St Clair J; Walgama ES; Lin DC; Nguyen AT; Zumsteg ZS
    Cancer; 2021 May; 127(10):1590-1597. PubMed ID: 33595897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Hawkins PG; Mierzwa ML; Bellile E; Jackson WC; Malloy KM; Chinn SB; Spector ME; Shuman AG; Stucken CL; McLean SA; Bradford CR; Prince ME; Carey TE; Worden FP; Swiecicki PL; Taylor JMG; Wolf GT; Eisbruch A; Casper KA
    Head Neck; 2019 Apr; 41(4):857-864. PubMed ID: 30775826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
    Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C; Shin DM; Beitler JJ; Patel MR; Aiken A; Saba NF
    Oncologist; 2022 Feb; 27(1):48-56. PubMed ID: 35305095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma.
    Haider SP; Zeevi T; Baumeister P; Reichel C; Sharaf K; Forghani R; Kann BH; Judson BL; Prasad ML; Burtness B; Mahajan A; Payabvash S
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma.
    Boot PA; Mes SW; de Bloeme CM; Martens RM; Leemans CR; Boellaard R; van de Wiel MA; de Graaf P
    Oral Oncol; 2023 Feb; 137():106307. PubMed ID: 36657208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric machine learning algorithm for human papillomavirus status and survival prediction in oropharyngeal cancer patients.
    Fazelpour S; Vejdani-Jahromi M; Kaliaev A; Qiu E; Goodman D; Andreu-Arasa VC; Fujima N; Sakai O
    Head Neck; 2023 Nov; 45(11):2882-2892. PubMed ID: 37740534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Context-Aware Saliency Guided Radiomics: Application to Prediction of Outcome and HPV-Status from Multi-Center PET/CT Images of Head and Neck Cancer.
    Lv W; Xu H; Han X; Zhang H; Ma J; Rahmim A; Lu L
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Events prediction after treatment in HPV-driven oropharyngeal carcinoma using machine learning.
    Dinia A; Ammari S; Filtes J; Classe M; Moya-Plana A; Bidault F; Temam S; Blanchard P; Lassau N; Gorphe P
    Eur J Cancer; 2022 Aug; 171():106-113. PubMed ID: 35714450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy.
    Porceddu SV; Milne R; Brown E; Bernard A; Rahbari R; Cartmill B; Foote M; McGrath M; Coward J; Panizza B
    Oral Oncol; 2017 Mar; 66():81-86. PubMed ID: 28249652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
    Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
    Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic stratification of oropharyngeal cancer patients in a betel nut chewing and low HPV area.
    Lee HP; Lee CC
    J Otolaryngol Head Neck Surg; 2023 Apr; 52(1):27. PubMed ID: 37081578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.